Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization. (2023)
Attributed to:
Aetiology and Mechanisms of Diabetes and Related Metabolic Disorders of Later Life
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.42538
PubMed Identifier: 37096546
Publication URI: http://europepmc.org/abstract/MED/37096546
Type: Journal Article/Review
Volume: 75
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
Issue: 10
ISSN: 2326-5191